Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
SHORT INTEREST
8.24M 07/15/19
P/E Current
-2.78
P/E Ratio (with extraordinary items)
-2.92
Average Recommendation: OVERWEIGHT
Average Target Price: 9.67
SHORT INTEREST
8.24M 07/15/19
P/E Current
-2.78
P/E Ratio (with extraordinary items)
-2.92
Average Recommendation: OVERWEIGHT
Average Target Price: 9.67
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Email Newsletter: dexwirenews.com/sign-up/
2) Text Message Notifications: dexwirenews.com/sms-newsletter/
3) Telegram: t.me/DEXWireNews
4) Follow Us on our Social Networks
1) Email Newsletter: dexwirenews.com/sign-up/
2) Text Message Notifications: dexwirenews.com/sms-newsletter/
3) Telegram: t.me/DEXWireNews
4) Follow Us on our Social Networks